Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Hydrogen Bromide | HCID 260 | — |
| Reactant | HCID 66734876 | HCID 66734876 | — |
| Product | HCID 46937585 | HCID 46937585 | 127.3% |
Reaction Steps
(2S,4S)-Methyl 4-(3-oxo-2,3-dihydroisoxazol-5-yl)-2-phenylpiperidine-1-carboxylate (249 mg, 0.82 mmol) was dissolved in hydrogen bromide (33% in acetic acid, 3 mL, 42.82 mmol) and the mixture was stirred at room temperature for 16 h. The solvent was evaporated and the residue was purified by preparative HPLC (Instrument: FractionLynx II, Mobilphase: gradient 5-95% MeCN in 0.2% NH3, pH 10, Column: Xbridge Prep C18 5 μm OBD 19*150 mm) to yield 5-((2S,4S)-2-phenylpiperidin-4-yl)isoxazol-3(2H)-one (255 mg, 127%) (the isolated sample contained DMSO). 1H NMR (400 MHz, cdcl3) δ 2.10-2.43 (m, 4H), 3.21 (dt, 1H), 3.26-3.35 (m, 1H), 3.35-3.43 (m, 1H), 4.17 (dd, 1H), 5.73 (s, 1H), 7.34-7.48 (m, 5H). HRMS Calculated for [C14H16N2O2+H]+: 245.1290. Found: 245.1271.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08415378B2 |
|---|
| Source dataset | uspto-grants-2013_04 |
|---|
| ORD ID | ord-32664080ca2147828ef33b7ac560d16d |
|---|
| Source note | uspto-grants-2013_04 |
|---|